Association Between Schizophrenia-Related Polygenic Liability and the Occurrence and Level of Mood-Incongruent Psychotic Symptoms in Bipolar Disorder.
Association Between Schizophrenia-Related Polygenic Liability and the Occurrence and Level of Mood-Incongruent Psychotic Symptoms in Bipolar Disorder.
复制标题
DOI:
10.1001/jamapsychiatry.2017.3485
复制
发表时间:
2018-01-01
期刊:
影响因子:
25.8
通讯作者:
Escott-Price V
中科院分区:
文献类型:
--
作者:
Allardyce J;Leonenko G;Hamshere M;Pardiñas AF;Forty L;Knott S;Gordon-Smith K;Porteous DJ;Haywood C;Di Florio A;Jones L;McIntosh AM;Owen MJ;Holmans P;Walters JTR;Craddock N;Jones I;O'Donovan MC;Escott-Price V
This case-control study examines the association between polygenic liability for schizophrenia and psychotic presentations of bipolar disorder. What is the association between schizophrenia-related polygenic liability and the occurrence and level of mood-incongruence of psychotic symptoms in bipolar disorder? In this case-control study involving 4436 cases of bipolar disorder, 4976 cases of schizophrenia, and 9012 controls, there was an exposure-response gradient of polygenic risk. Schizophrenia had the strongest association, followed by bipolar disorder with prominent mood-incongruent psychotic features, bipolar disorder with mood-congruent psychotic features, and bipolar disorder with no psychosis; all differential associations were statistically significant. This study shows a gradient of genetic liability across schizophrenia and bipolar disorder, indexed by the occurrence of psychosis and level of mood incongruence. Bipolar disorder (BD) overlaps schizophrenia in its clinical presentation and genetic liability. Alternative approaches to patient stratification beyond current diagnostic categories are needed to understand the underlying disease processes and mechanisms. To investigate the association between common-variant liability for schizophrenia, indexed by polygenic risk scores (PRSs), and psychotic presentations of BD. This case-control study in the United Kingdom used multinomial logistic regression to estimate differential PRS associations across categories of cases and controls. Participants included in the final analyses were 4436 cases of BD from the Bipolar Disorder Research Network. These cases were compared with the genotypic data for 4976 cases of schizophrenia and 9012 controls from the Type 1 Diabetes Genetics Consortium study and the Generation Scotland study. Data were collected between January 1, 2000, and December 31, 2013. Data analysis was conducted from March 1, 2016, to February 28, 2017. Standardized PRSs, calculated using alleles with an association threshold of P < .05 in the second Psychiatric Genomics Consortium genome-wide association study of schizophrenia, were adjusted for the first 10 population principal components and genotyping platforms. Multinomial logit models estimated PRS associations with BD stratified by Research Diagnostic Criteria subtypes of BD, by lifetime occurrence of psychosis, and by lifetime mood-incongruent psychotic features. Ordinal logistic regression examined PRS associations across levels of mood incongruence. Ratings were derived from the Schedules for Clinical Assessment in Neuropsychiatry interview and the Bipolar Affective Disorder Dimension Scale. Of the 4436 cases of BD, 2966 (67%) were female patients, and the mean (SD) age at interview was 46 [12] years. Across clinical phenotypes, there was an exposure-response gradient, with the strongest PRS association for schizophrenia (risk ratio [RR] = 1.94; 95% CI, 1.86-2.01), followed by schizoaffective BD (RR = 1.37; 95% CI, 1.22-1.54), bipolar I disorder subtype (RR = 1.30; 95% CI, 1.24-1.36), and bipolar II disorder subtype (RR = 1.04; 95% CI, 0.97-1.11). Within BD cases, there was an effect gradient, indexed by the nature of psychosis. Prominent mood-incongruent psychotic features had the strongest association (RR = 1.46; 95% CI, 1.36-1.57), followed by mood-congruent psychosis (RR = 1.24; 95% CI, 1.17-1.33) and BD with no history of psychosis (RR = 1.09; 95% CI, 1.04-1.15). For the first time to date, a study shows a polygenic-risk gradient across schizophrenia and BD, indexed by the occurrence and level of mood-incongruent psychotic symptoms.
登录
查看更多内容
DOI:
10.1177/1740774510373497
发表时间:
2010
期刊:
Clinical trials (London, England)
影响因子:
--
作者:
Hilner JE;Perdue LH;Sides EG;Pierce JJ;Wägner AM;Aldrich A;Loth A;Albret L;Wagenknecht LE;Nierras C;Akolkar B;T1DGC
通讯作者:
T1DGC
影响因子:
2.1
作者:
Dudbridge F
通讯作者:
Dudbridge F
影响因子:
9.2
作者:
Chang CC;Chow CC;Tellier LC;Vattikuti S;Purcell SM;Lee JJ
通讯作者:
Lee JJ
影响因子:
6.6
作者:
Derks, Eske M.;Allardyce, Judith;Ophoff, Roel A.
通讯作者:
Ophoff, Roel A.
影响因子:
4.4
作者:
Amador, Carmen;Huffman, Jennifer;Haley, Chris S.
通讯作者:
Haley, Chris S.